Table 2.
Response rate of group A and group B.
| Response status | RMA (group A, n=59) | RMA+ Ibrutinib (group B, n=29) | p Value |
|---|---|---|---|
| CR | 10 (16.9) | 12 (41.4) | 0.013 |
| PR | 25 (42.4) | 13 (44.8) | 0.827 |
| SD | 14 (23.7) | 2 (6.9) | 0.054 |
| PD | 10 (16.9) | 2 (6.9) | 0.323 |
| ORR | 35 (59.3) | 25 (86.2) | 0.011 |
RMA, rituximab + methotrexate + cytarabine; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; ORR, overall response rate.
Bold values: P < 0.05.